News Daily News NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin L.A. McKeown January 02, 2018
News Daily News ACC Provides Guidance on How to Manage Bleeding in Patients Taking Oral Anticoagulants Todd Neale December 04, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Daily News NOAC Bleeding Risk Rises With Several Drug Combinations Michael O'Riordan October 06, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Conference News VIVA 2017 Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients L.A. McKeown September 11, 2017
News Daily News In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs Shelley Wood August 10, 2017
News Daily News Women With A-fib Less Likely to Get Oral Anticoagulants Regardless of Risk Leah Lawrence August 03, 2017
News Daily News Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI L.A. McKeown May 23, 2017
News Daily News Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women Todd Neale May 11, 2017
News Daily News More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds Todd Neale May 05, 2017
News Daily News ‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum Todd Neale April 27, 2017
News Daily News If You Don’t Take Your Stroke Meds, This App Will Tell on You Todd Neale April 18, 2017
News Daily News Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows Michael O'Riordan March 31, 2017
News Daily News Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions Todd Neale March 28, 2017
News Conference News ACC 2017 Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them Yael L. Maxwell March 23, 2017
News Conference News ACC 2017 Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE L.A. McKeown March 18, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017